Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Impact of a FDA Breakthrough designation

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 23, 2022 6:16pm

113 Views

Post# 34626626

RE:RE:Impact of a FDA Breakthrough designation

Hey Lazer,

Just an idea on my part but I think the COvid 19 grant would come from/through Public Health Canada, via a partnership/licensing of TLTs tech?

TLT does have FT and yes that should mean BTD will come easily. TLT doesn't have all the patient data they'd need for that, yet...

LaserStock29 wrote: Has Theralase utilized it's fast track as to get a 'rolling review' and keep communications with FDA.. and get a BTD going and not wait to submit a full package at once.. where shareholders will look at an NR.saying wait another 60 days until the AGM?

Has Theralase applied for a grant for covid 19.. usually these grants take a good bit of time.. aka terry fox grant. 1 year.

Been 8 years of reading how other companies valuations go up for one reason or another and we get jackshi*.

Id sure like to know how THeralase has utilized the Fast track designation in forwarding the BTD efforts..as so that we dont get kicked in the nuts with a hey it's MAY annual and wait 60 days